When to diagnose and how to treat prostate cancer in the 'not too fit' elderly

Critical Reviews in Oncology/Hematology

Volumn 48, Issue 2, 2003, Pages 123-131

  Dahm, Philipp ^a   Silverstein, Ari D ^a   Weizer, Alon Z ^a   Crisci, Alfonso ^a   Vieweg, Johannes ^a   Paulson, David F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aged; Outcome; Prostatectomy; Prostatic neoplasms

Indexed keywords

AGED; CANCER MORTALITY; CANCER SURVIVAL; CAUSE OF DEATH; CONFERENCE PAPER; CONTROLLED STUDY; FITNESS; FOLLOW UP; GERIATRIC DISORDER; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL RATE;

EID: 0242352375     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2003.04.003     Document Type: Conference Paper

References (31)

1. Ruchlin H.S., Pellissier J.M. An economic overview of prostate carcinoma. Cancer. 92:2001;2796-2810.
2. Holmberg L., Bill-Axelson A., Helgesen F., Salo J.O., Folmerz P., Haggman M.et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl. J. Med. 347:2002;781-789.
3. Albertsen P.C., Hanley J.A., Gleason D.F., Barry M.J. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. J. Am. Med. Assoc. 280:1998;975-980.
4. Krahn M.D., Bremner K.E., Asaria J., Alibhai S.M., Nam R., Tomlinson G. et al. The ten-year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer. Urology. 60:2002;258-263.
5. Iselin C.E., Robertson J.E., Paulson D.F. Radical perineal prostatectomy: oncological outcome during a 20-year period. J. Urol. 161:1999;163-168.
6. Paulson D.F. Impact of radical prostatectomy in the management of clinically localized disease. J. Urol. 152:1994;1826-1830.
7. Sweat S.D., Bergstralh E.J., Slezak J., Blute M.L., Zincke H. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age. J. Urol. 168:2002;525-529.
8. Gregori A., Vieweg J., Dahm P., Paulson D.F. Comparison of ultrasound-guided biopsies and prostatectomy specimens: predictive accuracy of Gleason score and tumor site. Urol. Int. 66:2001;66-71.
9. San Francisco I.F., DeWolf W.C., Rosen S., Upton M., Olumi A.F. Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy. J. Urol. 169:2003;136-140.
10. Smith E.B., Frierson H.F. Jr., Mills S.E., Boyd J.C., Theodorescu D. Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading. Cancer. 94:2002;2282-2287.
11. Quinlan D.M., Partin A.W., Walsh P.C. Can aggressive prostatic carcinomas be identified and can their natural history be altered by treatment. Urology. 46:1995;77-82.
12. Egevad L., Granfors T., Karlberg L., Bergh A., Stattin P. Percent Gleason grade 4/5 as prognostic factor in prostate cancer diagnosed at transurethral resection. J. Urol. 168:2002;509-513.
13. Ohori M., Goad J.R., Wheeler T.M., Eastham J.A., Thompson T.C., Scardino P.T. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer. J. Urol. 152:1994;1843-1849.
14. Perrotti M., Rabbani F., Farkas A., Ward W.S., Cummings K.B. Trends in poorly differentiated prostate cancer 1973 to 1994: observations from the surveillance, epidemiology and end results database. J. Urol. 160:1998;811-815.
15. Gillitzer R., Thuroff J. Relative advantages and disadvantages of radical perineal prostatectomy versus radical retropubic prostatectomy. Crit. Rev. Oncol. Hematol. 43:2002;167.
16. Gingrich J.R., Paulson D.F. The impact of PSA on prostate cancer management. Can we abandon routine staging pelvic lymphadenectomy. Surg. Oncol. Clin. North Am. 4:1995;335-344.
17. Partin A.W., Kattan M.W., Subong E.N., Walsh P.C., Wojno K.J., Oesterling J.E.et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update [see comments]. J. Am. Med. Assoc. 277:1997;1445-1451.
18. Frazier H.A., Robertson J.E., Paulson D.F. Radical prostatectomy: the pros and cons of the perineal versus retropubic approach. J. Urol. 147:1992;888-890.
19. Lance R.S., Freidrichs P.A., Kane C., Powell C.R., Pulos E., Moul J.W.et al. A comparison of radical retropubic with perineal prostatectomy for localized prostate cancer within the Uniformed Services Urology Research Group. BJU Int. 87:2001;61-65.
20. Sullivan L.D., Weir M.J., Kinahan J.F., Taylor D.L. A comparison of the relative merits of radical perineal and radical retropubic prostatectomy. BJU Int. 85:2000;95-100.
21. Ruiz-Deya G, Davis R, Srivastav SK, Wise AM, Thomas R. Outpatient radical prostatectomy: impact of standard perineal approach on patient outcome. J. Urol. 2001;166:581-6.
22. Wei J.T., Dunn R.L., Sandler H.M., McLaughlin P.W., Montie J.E., Litwin M.S.et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J. Clin. Oncol. 20:2002;557-566.
23. Gibbons RP. Total prostatectomy for clinically localized prostate cancer: long-term surgical results and current morbidity, NCI Monographs 1988;123-6.
24. Weldon V.E., Tavel F.R., Neuwirth H. Continence, potency and morbidity after radical perineal prostatectomy. J. Urol. 158:1997;1470-1475.
25. Bishoff J.T., Motley G., Optenberg S.A., Stein C.R., Moon K.A., Browning S.M.et al. Incidence of fecal and urinary incontinence following radical perineal and retropubic prostatectomy in a national population. J. Urol. 160:1998;454-458.
26. Litwin M.S., Flanders S.C., Pasta D.J., Stoddard M.L., Lubeck D.P., Henning J.M. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology. 54:1999;503-508.
27. Sokoloff M.H., Brendler C.B. Indications and contraindications for nerve-sparing radical prostatectomy. Urol. Clin. North. Am. 28:2001;535-543.
28. Rabbani F., Stapleton A.M., Kattan M.W., Wheeler T.M., Scardino P.T. Factors predicting recovery of erections after radical prostatectomy. J. Urol. 164:2000;1929-1934.
29. Han M., Partin A.W. Nomograms for clinically localized prostate cancer. Part I. Radical prostatectomy. Semin. Urol. Oncol. 20:2002;123-130.
30. Penson D.F., Albertsen P.C., Nelson P.S., Barry M., Stanford J.L. Determining cause of death in prostate cancer: are death certificates valid. J. Natl. Cancer Inst. 93:2001;1822-1823.
31. Albertsen P.C., Walters S., Hanley J.A. A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995. J. Urol. 163:2000;519-523.